Madrigal Pharmaceuticals Revenue, Growth & Competitor Profile

DBA MADRIGAL PHARMACEUTICALS, INC. (FORMERLY, SYNTA PHARMACEUTICALS, INC.)
DBA SHIONOGI BIORESEARCH
DBA SYNTA PHARMACEUTICALS CORP.

Company Profile & Annual Report for Madrigal Pharmaceuticals

Access the complete profile.

Madrigal Pharmaceuticals Fast Facts

Revenue	$10 - $100 million    See Exact Annual Revenue
Employees	10 - 100Exact Company Size
Primary Industry	5417 Scientific Research & Development Services
Address	200 Barr Harbor Drive, Suite 400 West Conshohocken, PA 19428

Madrigal Pharmaceuticals's Annual Report & Profile shows critical firmographic facts:

• What is the company's size? (Annual sales and employees)
  • Madrigal Pharmaceuticals's annual revenues are $10 - $100 million (see exact revenue data)
• What industry is the company in?
  • Madrigal Pharmaceuticals is classified as operating in the Scientific Research & Development Services industry, NAICS Code 5417.

Madrigal Pharmaceuticals is a publicly traded company on using the ticker symbol SNTA. Detailed information on company financials and operating reports can be found here: : SNTA

Madrigal Pharmaceuticals Annual Revenue and Growth Rate

Madrigal Pharmaceuticals	Revenue Est. ($ Million)	Growth Rate (%)	# Employees
2025	$10 - $100 million Details in Premium Report
2024
2023
2021
2020
2019

1-Year Growth Rate: 3-Year Growth Rate (CAGR):

Note: Madrigal Pharmaceuticals's revenues are gauged from an analysis of company filings.

Investor Activity

Madrigal Pharmaceuticals has actively raised capital from investors. These investors may include private investors, venture capital firms, or other investment vehicles.

Date	Investors	Percent Raised	Target Size
July 5, 2017	5	100%	$35 MM
Complete list of funding rounds and total amounts in the Company Report

Trademark Applications

Trademark applications show the products and services that Madrigal Pharmaceuticals is developing and marketing. Madrigal Pharmaceuticals doesn't have any recent trademark applications, indicating Madrigal Pharmaceuticals is focusing on its existing business rather than expanding into new products and markets. Trademarks may include brand names, product names, logos and slogans.

Trademark	Date
RESFIBSY Pharmaceutical preparations for the treatment of patients with non-alcoholic steatohepatitis (NASH) with liver fibrosis	12/22/2023
REZDIFFRA Pharmaceutical preparations for the treatment of patients with non-alcoholic steatohepatitis (NASH) with liver fibrosis	12/22/2023
THIRBEZDY Pharmaceutical preparations for the treatment of patients with non-alcoholic steatohepatitis (NASH) with liver fibrosis	12/22/2023

See all trademarks and details in the Full Report.

Market Share of Madrigal Pharmaceuticals's Largest Competitors

A competitive analysis shows these companies are in the same general field as Madrigal Pharmaceuticals, even though they may not compete head-to-head. These are the largest companies by revenue. However, they may not have the largest market share in this industry if they have diversified into other business lines. The "Competition" section of a business plan or investment memorandum would start by analyzing the information about these companies. Competitive advantage comes from offering better pricing or superior products/service.

Company	Headquarters	Revenue ($ MM)
LEIDOS	Denver, CO	100
NATIONAL TECHNOLOGY & ENGINEERING SOLUTIONS OF SANDIA	Albuquerque, NM	30
INC RESEARCH	Raleigh, NC	27
RESEARCH FOUNDATION FOR STATE UNIVERSITY OF NEW YORK	Albany, NY	17
FLUOR MARINE PROPULSION	West Mifflin, PA	15
SYNEOS HEALTH	Raleigh, NC	13
ILLUMINA	San Diego, CA	12
UT-BATTELLE	Oak Ridge, TN	11
PRA HOLDINGS	Raleigh, NC	11

Nearby Competitors

These companies are similar in business line and location to Madrigal Pharmaceuticals. While some companies compete with neighboring businesses for customers, other companies may compete to attract skilled employees.

Company	Headquarters	Revenue ($ MM)
PSI PHARMA SUPPORT AMERICA	King Of Prussia, PA	100
INOVIO PHARMACEUTICALS	Plymouth Meeting, PA	38
TRANSFORMATIVE PHARMACEUTICAL SOLUTIONS	Blue Bell, PA	37
ROCKLAND IMMUNOCHEMICALS	Pottstown, PA	30
MADRIGAL PHARMACEUTICALS	West Conshohocken, PA	26
ZEROEYES	Conshohocken, PA	22

Other Companies at 200 Barr Harbor Drive, Suite 400, West Conshohocken PA

Company	Headquarters	Revenue ($ MM)
TRILION QUALITY SYSTEMS	West Conshohocken, PA	100
AUA CAPITAL MANAGEMENT	West Conshohocken, PA	71
ROSEMONT INVESTMENT PARTNERS	W. Conshohocken, PA	17
IRONVIEW CAPITAL MANAGEMENT	Conshohocken, PA	0

Future Competition: Madrigal Pharmaceuticals's Fastest Growing Competitors

These companies are in the same general field as Madrigal Pharmaceuticals and are rapidly expanding. Companies may grow organically or through acquisition. In some cases apparently high growth rates may be caused by data that weren't available in previous years.

Company	Revenue ($ MM)